HCM
ELV icon

Highbridge Capital Management’s Elevance Health ELV Stock Holding History

Highbridge Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-5,000
Closed -$716K – 1489
2016
Q4 		$716K Buy
5,000
+2,500
+100% +$335K 0.01% 647
2016
Q3 		$315K Buy
+2,500
New +$323K 0.01% 991
2016
Q1 		– Sell
-1,600
Closed -$223K – 1570
2015
Q4 		$223K Buy
+1,600
New +$220K ﹤0.01% 1294

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Highbridge Capital Management's ELV Position: Q1 2018 in Review

Highbridge Capital Management sold out of Elevance Health (ELV) in Q1 2018, closing a stake of 14,656 shares — an estimated $3.3M sold.

Highbridge Capital Management first reported a position in ELV in Q3 2013 and held it in 12 quarters. The position peaked at $30.1M in Q2 2016. 924 funds tracked by Wall St. Rank hold ELV as of Q1 2018.

  • Highbridge Capital Management reported no remaining Elevance Health position as of Q1 2018 after selling out during the quarter.
  • Highbridge Capital Management sold 14,656 Elevance Health shares in Q1 2018, an estimated $3.3M.
  • Highbridge Capital Management first reported a position in Elevance Health in Q3 2013 and held it in 12 quarters.
  • Highbridge Capital Management's Elevance Health position peaked at $30.1M in Q2 2016.
  • 924 funds tracked by Wall St. Rank held Elevance Health as of Q1 2018.

Based on Highbridge Capital Management's 13F filing for Q1 2018, filed 15 May 2018.